Customize your JAMA Network experience by selecting one or more topics from the list below.
Three and a half months after coronavirus disease 2019 (COVID-19) breached Latin America’s borders, a bit of optimism emerged in hard-hit Brazil, where case numbers have surpassed 700 000. Brazilian regulatory authorities on June 2 approved the country’s participation in the University of Oxford’s severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine trial supported by AstraZeneca. Two days later, the Lemann Foundation, which supports public education in Brazil, announced that it would fund half of the country’s 2000 volunteers participating in the initial round of trials.
As the first nation outside of the UK to test the Oxford vaccine, Brazil’s involvement is “an important milestone,” the foundation’s executive director, Denis Mizne, said in a statement. Yet even though Latin America’s largest country is playing a vital role in the worldwide quest for a safe, effective vaccine, the pandemic is further stressing a part of the world that’s already vulnerable from rising levels of poverty and inequality, as well as outbreaks in recent years of Zika virus, chikungunya, measles, and several other infectious diseases.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Rubin R, Abbasi J, Voelker R. Latin America and Its Global Partners Toil to Procure Medical Supplies as COVID-19 Pushes the Region to Its Limit. JAMA. 2020;324(3):217–219. doi:10.1001/jama.2020.11182
Create a personal account or sign in to: